---
title: "MedicQuant ApS – CVR 40732829, financials and ownership"
description: "MedicQuant ApS (CVR 40732829). Active · Fremstilling af medicinske og dentale instrumenter samt udstyr hertil · Aarhus N. 13 employees (CVR). Gross profit 1.9M DKK (2025)."
canonical_url: "https://datapublica.dk/en/companies/40732829-medicquant-aps"
locale: "en"
route_type: "company_overview"
robots: "index,follow"
---

# MedicQuant ApS

MedicQuant ApS \(CVR 40732829\). Active · Fremstilling af medicinske og dentale instrumenter samt udstyr hertil · Aarhus N. 13 employees \(CVR\). Gross profit 1.9M DKK \(2025\).

CVR number: 40732829

## Company details

- **CVR number:** 40732829

- **Status:** Aktiv

- **Address:** Palle Juul-Jensens Boulevard 82, 8200, Aarhus N

- **Legal form:** Anpartsselskab \(ApS\)

- **Founded:** Aug 22, 2019

- **Employees \(CVR\):** 13

- **Production units:** 1

- **Website:** https://www.medicquant.com/

- **LinkedIn:** medicquant

## Description

MedicQuant is a spin-out from the Gothelf Lab at iNANO, Aarhus University, Denmark, developing a proprietary, patent-pending DNA nanotechnology platform for precise measurement of small molecules and a point-of-care system for quantifying small-molecule drugs in blood.

MedicQuant develops disposable cartridge-based diagnostic assays and a fluorescence reader system that measure small-molecule drug concentrations directly from whole blood in approximately 10 minutes. The assays are currently being developed for anticoagulants, with proof of concept demonstrated for antibiotics, anticancer drugs, and antirheumatic drugs.

### Company's own description on virk.dk

Description of key activities of the companyThe purpose of the company is to develop and manufacture medical devices and reagents for in vitro diagnostic purpose.

### Products & services

DNA nanotechnology platform for measuring small molecules • Point-of-care system for quantifying small-molecule drugs in blood • Disposable MedicQuant cartridge • Flow-front immunoassay • Fluorescence readout using FRET • Diagnostic assays for anticoagulants • Proof-of-concept assays for antibiotics, anticancer drugs, and antirheumatic drugs

### Industries

Healthcare • Biotechnology • Medical diagnostics

### Customer types

Emergency departments • End users at relevant sites

## Activities and industry

- Fremstilling af medicinske og dentale instrumenter samt udstyr hertil

- 325000 — Fremstilling af medicinske og dentale instrumenter samt udstyr hertil

## Latest financial period

- **Reporting period:** 2025

- **Currency:** DKK

- **Gross profit:** 1,911,164

- **Operating profit:** -1,098,767

- **Profit after tax:** -741,962

- **Assets:** 11,457,858

- **Equity:** 10,000,226

## Founders

| Founder | Registered as founder | Current roles | Ownership |
| --- | --- | --- | --- |
| [Line Debois Frejlev Nielsen](https://datapublica.dk/en/people/pid_entity_4008175486-line-debois-frejlev-nielsen) | Aug 22, 2019 | Board, Management | Indirect owner · unknown stake |
| [Malthe Hansen-Bruhn](https://datapublica.dk/en/people/pid_entity_4008175485-malthe-hansen-bruhn) | Aug 22, 2019 | Management | Indirect owner · unknown stake |

## People

| Person | Roles | Titles |
| --- | --- | --- |
| [Kevin Leig Bengtsson](https://datapublica.dk/en/people/pid_entity_4004024625-kevin-leig-bengtsson) | Board | FORMAND |
| [Line Debois Frejlev Nielsen](https://datapublica.dk/en/people/pid_entity_4008175486-line-debois-frejlev-nielsen) | Board • Management | BESTYRELSESMEDLEM • ADM. DIR. |
| [Mathias Brink Lorenz](https://datapublica.dk/en/people/pid_entity_4000628523-mathias-brink-lorenz) | Board | BESTYRELSESMEDLEM |
| [Søren Danielsen Juhl](https://datapublica.dk/en/people/pid_entity_4010343619-s-ren-danielsen-juhl) | Board | BESTYRELSESMEDLEM |
| [Malthe Hansen-Bruhn](https://datapublica.dk/en/people/pid_entity_4008175485-malthe-hansen-bruhn) | Management | DIREKTØR |

## Auditor

| Audit firm | Auditor | Role | From |
| --- | --- | --- | --- |
| Grant Thornton, Godkendt Revisionspartnerselskab | Morten Høgh-Petersen | statsautoriseret revisor | Jun 23, 2026 |

## Contact

### From [cvr.dk](https://datacvr.virk.dk/)

Advertising protected

Contact details from CVR must not be used for direct marketing when the entity is advertising protected. The protection does not cover details collected from the company’s own website. The general marketing rules still apply. [Read more at the Danish Business Authority](https://virksomhedsguiden.dk/content/ydelser/faa-reklamebeskyttet-din-virksomhed-i-cvr/3337006d-3b93-4bb0-bc08-82a0915c0332/)

Protected entities: Company; MedicQuant ApS · Palle Juul-Jensens Boulevard 82 · P-1024966689

| Contact | Phone | Email |
| --- | --- | --- |
| Company | 3122\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F40732829-medicquant-aps) | in\*\*@medicquant.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F40732829-medicquant-aps) |

Branches \(1\)

MedicQuant ApS · Palle Juul-Jensens Boulevard 82 · P-1024966689

| Contact | Phone | Email |
| --- | --- | --- |
| Company | 3122\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F40732829-medicquant-aps) | li\*\*@debois.dk [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F40732829-medicquant-aps) |

## Legal owners

### Current

| Owner | Ownership | Voting rights | From |
| --- | --- | --- | --- |
| OwnerDanmarks Eksport- og Investeringsfond | Ownership20–24.99 % | Voting rights20 % | FromMar 31, 2023 |
| OwnerBENGTSSON HOLDING ApS | Ownership10–14.99 % | Voting rights10 % | FromMar 30, 2023 |
| OwnerBruhn Initiative ApS | Ownership10–14.99 % | Voting rights10 % | FromFeb 20, 2026 |
| OwnerDebois ApS | Ownership10–14.99 % | Voting rights10 % | FromFeb 20, 2026 |
| OwnerDelphinus Venture Capital K/S | Ownership10–14.99 % | Voting rights10 % | FromFeb 20, 2026 |
| OwnerDen Midtjyske Iværksætterfond | Ownership5–9.99 % | Voting rights5 % | FromAug 17, 2026 |
| OwnerGothelf ApS | Ownership5–9.99 % | Voting rights5 % | FromMar 30, 2023 |

### Previous

| Owner | Ownership | Voting rights | From | To |
| --- | --- | --- | --- | --- |
| OwnerWaarst Holding ApS | Ownership5–9.99 % | Voting rights5 % | FromMar 30, 2023 | ToFeb 20, 2026 |
| OwnerBruhn Initiative ApS | Ownership15–19.99 % | Voting rights15 % | FromMar 30, 2023 | ToFeb 19, 2026 |
| OwnerDebois ApS | Ownership15–19.99 % | Voting rights15 % | FromMar 30, 2023 | ToFeb 19, 2026 |
| OwnerGothelf ApS | Ownership15–19.99 % | Voting rights15 % | FromMay 9, 2022 | ToMar 29, 2023 |
| OwnerBruhn Initiative ApS | Ownership25–33.32 % | Voting rights25 % | FromOct 7, 2021 | ToMar 29, 2023 |
| OwnerDebois ApS | Ownership25–33.32 % | Voting rights25 % | FromOct 7, 2021 | ToMar 29, 2023 |
| OwnerBENGTSSON HOLDING ApS | Ownership10–14.99 % | Voting rights10 % | FromOct 7, 2021 | ToMar 29, 2023 |
| OwnerWaarst Holding ApS | Ownership10–14.99 % | Voting rights10 % | FromOct 7, 2021 | ToMar 29, 2023 |
| OwnerGothelf ApS | Ownership20–24.99 % | Voting rights20 % | FromOct 7, 2021 | ToMay 8, 2022 |
| OwnerBruhn Initiative ApS | Ownership33.33–49.99 % | Voting rights33.33 % | FromAug 31, 2020 | ToOct 6, 2021 |
| OwnerDebois ApS | Ownership33.33–49.99 % | Voting rights33.33 % | FromAug 31, 2020 | ToOct 6, 2021 |
| OwnerGothelf ApS | Ownership33.33–49.99 % | Voting rights33.33 % | FromAug 22, 2019 | ToOct 6, 2021 |
| OwnerLine Debois Frejlev Nielsen | Ownership33.33–49.99 % | Voting rights33.33 % | FromAug 22, 2019 | ToAug 31, 2020 |
| OwnerMalthe Hansen-Bruhn | Ownership33.33–49.99 % | Voting rights33.33 % | FromAug 22, 2019 | ToAug 31, 2020 |

## Ultimate owners

The structure contains circular ownership. Aggregate stakes cannot be calculated reliably.
[View ownership diagram](https://datapublica.dk/en/companies/40732829-medicquant-aps/portfolio)
| Name | Ownership through | Calculated ownership |
| --- | --- | --- |
| AARHUS UNIVERSITETS FORSKNINGSFOND | AUFF Holding P/S → Delphinus Venture Capital K/S | Unknown stake |
| Anders Holch Povlsen | HEARTLAND A/S → Brightfolk A/S → Delphinus Venture Capital K/S | Unknown stake |
| Astrid Storm Holch Povlsen | HEARTLAND A/S → Brightfolk A/S → Delphinus Venture Capital K/S | Unknown stake |
| Danmarks Eksport- og Investeringsfond | Direct | Unknown stake |
| Den Midtjyske Iværksætterfond | Direct | Unknown stake |
| Kevin Leig Bengtsson | BENGTSSON HOLDING ApS | Unknown stake |
| KØBMAND FERDINAND SALLINGS MINDEFOND | F. SALLING HOLDING A/S → Salling Group A/S → Delphinus Venture Capital K/S | Unknown stake |
| KØBMAND HERMAN SALLINGS FOND | F. SALLING HOLDING A/S → Salling Group A/S → Delphinus Venture Capital K/S / F. SALLING INVEST A/S → Salling Group A/S → Delphinus Venture Capital K/S | Unknown stake |
| Kurt Vesterager Gothelf | Gothelf ApS | Unknown stake |
| Line Debois Frejlev Nielsen | Debois ApS | Unknown stake |
| Malthe Hansen-Bruhn | Bruhn Initiative ApS | Unknown stake |
| Norlys a.m.b.a. | Delphinus Venture Capital K/S | Unknown stake |

## Company pages

- [Overview](https://datapublica.dk/en/companies/40732829-medicquant-aps)

- [Financial report](https://datapublica.dk/en/companies/40732829-medicquant-aps/financials)

- [Risk](https://datapublica.dk/en/companies/40732829-medicquant-aps/risk)

- [Timeline](https://datapublica.dk/en/companies/40732829-medicquant-aps/timeline)

- [Ownership and relations](https://datapublica.dk/en/companies/40732829-medicquant-aps/portfolio)

- [Production units](https://datapublica.dk/en/companies/40732829-medicquant-aps/production-units)

- [Gazelle](https://datapublica.dk/en/companies/40732829-medicquant-aps/gazelle)

- [Investments](https://datapublica.dk/en/companies/40732829-medicquant-aps/investments)

- [Company website](https://www.medicquant.com/)

## Official sources

- [Official CVR record on Virk](https://datacvr.virk.dk/enhed/virksomhed/40732829)
